A5006593420- Aging, Elder Care, and Social Issues
- Dementia and Cognitive Impairment Research
- Health, Medicine and Society
- Health disparities and outcomes
- Peripheral Artery Disease Management
- Migration, Identity, and Health
- Nutrition and Health in Aging
- Nutritional Studies and Diet
- Intergenerational Family Dynamics and Caregiving
- Healthcare Systems and Practices
- Health, Environment, Cognitive Aging
- Health Systems, Economic Evaluations, Quality of Life
- Global Health Care Issues
- Health and Well-being Studies
- Blood Pressure and Hypertension Studies
- Alzheimer's disease research and treatments
- HIV/AIDS Impact and Responses
- Agriculture and Rural Development Research
- Chronic Disease Management Strategies
- Child Nutrition and Water Access
- Parasites and Host Interactions
- Cardiovascular Health and Disease Prevention
- Social Policies and Family
- Musculoskeletal pain and rehabilitation
- Diabetes, Cardiovascular Risks, and Lipoproteins
Institut d’Epidémiologie Neurologique et de Neurologie Tropicale
2015-2024
Institut d’Epidémiologie et de Neurologie Tropicale
2014-2024
Université de Limoges
2015-2024
Inserm
2015-2024
Université d'Abomey-Calavi
2010-2024
UNSW Sydney
2024
Institut de Recherche pour le Développement
2020-2024
University of Hull
2023
Witten/Herdecke University
2023
University of Bologna
2023
Abstract Introduction In 2010, Alzheimer's Disease International presented estimates of the global cost illness (COI) dementia. Since then, new studies have been conducted, and number people with dementia has increased. Here, we present an update estimates. Methods This is a societal, prevalence‐based COI study. Results The worldwide costs were estimated at United States (US) $818 billion in 2015, increase 35% since 2010; 86% occur high‐income countries. Costs informal care direct social...
Abstract Introduction Dementia is a leading cause of death and disability globally. Estimating total societal costs demonstrates the wide impact dementia its main direct indirect economic components. Methods We constructed global cost model for dementia, presenting as cumulated regional costs. Results In 2019, annual were estimated at US $1313.4 billion 55.2 million people with corresponding to $23,796 per person dementia. Of total, $213.2 (16%) medical costs, $448.7 (34%) social sector...
There are several existing systematic reviews of prevalence dementia for mainland China, Hong Kong and Taiwan, but studies have been newly reported. The aim this study is to update data in region test variation across geographical areas time periods using the new dataset.
Abstract Background Subjective cognitive decline (SCD) is recognized as a risk stage for Alzheimer’s disease (AD) and other dementias, but its prevalence not well known. We aimed to use uniform criteria better estimate SCD across international cohorts. Methods combined individual participant data 16 cohorts from 15 countries (members of the COSMIC consortium) used qualitative quantitative (Item Response Theory/IRT) harmonization techniques prevalence. Results The sample comprised 39,387...
<i>Background:</i> Data on dementia from low- and middle-income countries are still necessary to quantify the burden of this condition. This multicenter cross-sectional study aimed at estimating prevalence in 2 large cities Central Africa. <i>Methods:</i> General population door-to-door surveys were conducted districts Bangui (Republic Africa) Brazzaville (Congo) elderly aged ≧65 years. The subjects screened with Community Screening Interview for Dementia Five-Words...
empirical evidence from high-income countries suggests that self-rated health (SRH) is useful as a brief and simple outcome measure in public research. However, many low- middle-income (LMIC) there lack of evaluation the cross-cultural validity SRH remains largely untested. This study aims to explore prevalence its association with mortality older adults LMIC order cross-culturally validate construct SRH. population-based cohort studies including 16,940 persons aged ≥65 years China, India,...
Systolic interarm differences in blood pressure have been associated with all-cause mortality and cardiovascular disease. We undertook individual participant data meta-analyses to (1) quantify independent associations of systolic difference events; (2) develop validate prognostic models incorporating difference, (3) determine whether remains risk after adjustment for common scores. searched studies recording bilateral outcomes, established agreements collaborating authors, created a single...